Toxic epidermal necrolysis in a patient receiving vemurafenib for treatment of metastatic malignant melanoma
Author:
Affiliation:
1. Department of Dermatology; Chelsea and Westminster Hospital; 369 Fulham Road London SW10 9NH U.K.
2. Department of Oncology; University of Oxford; Oxford U.K.
Publisher
Wiley
Subject
Dermatology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/bjd.12796/fullpdf
Reference4 articles.
1. Improved survival with vemurafenib in melanoma with BRAF V600E mutation;Chapman;N Engl J Med,2011
2. Cutaneous adverse events associated with vemurafenib in patients with metastatic melanoma: practical advice on diagnosis, prevention and management of the main treatment-related skin toxicities;Sinha;Br J Dermatol,2012
3. SCORTEN: a severity-of-illness score for toxic epidermal necrolysis;Bastuji-Garin;J Invest Dermatol,2000
4. Toxic epidermal necrolysis: Part I. Introduction, history, classification, clinical features, systemic manifestations, etiology, and immunopathogenesis;Schwartz;J Am Acad Dermatol,2013
Cited by 29 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Emerging Insights into Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis Induced by Immune Checkpoint Inhibitor and Tumor-Targeted Therapy;Journal of Inflammation Research;2024-04
2. Cutaneous adverse reactions resulting from targeted cancer therapies: histopathologic and clinical findings;Human Pathology;2023-10
3. Evaluation of Delayed-Type Hypersensitivity to Antineoplastic Drugs—An Overview;Cancers;2023-02-14
4. Epidermal necrolysis in the context of immuno‐oncologic medication as well as kinase inhibitors and biologics;JDDG: Journal der Deutschen Dermatologischen Gesellschaft;2022-06
5. Epidermale Nekrolyse im Zusammenhang mit immunonkologischen Medikamenten, Kinaseinhibitoren sowie Biologika;JDDG: Journal der Deutschen Dermatologischen Gesellschaft;2022-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3